185 related articles for article (PubMed ID: 11148800)
21. A comprehensive review of treatments for postmenopausal osteoporosis.
Häuselmann HJ; Rizzoli R
Osteoporos Int; 2003 Jan; 14(1):2-12. PubMed ID: 12577179
[TBL] [Abstract][Full Text] [Related]
22. Meta-analyses of therapies for postmenopausal osteoporosis. VII. Meta-analysis of calcium supplementation for the prevention of postmenopausal osteoporosis.
Shea B; Wells G; Cranney A; Zytaruk N; Robinson V; Griffith L; Ortiz Z; Peterson J; Adachi J; Tugwell P; Guyatt G;
Endocr Rev; 2002 Aug; 23(4):552-9. PubMed ID: 12202470
[TBL] [Abstract][Full Text] [Related]
23. Five years treatment with strontium ranelate reduces vertebral and nonvertebral fractures and increases the number and quality of remaining life-years in women over 80 years of age.
Seeman E; Boonen S; Borgström F; Vellas B; Aquino JP; Semler J; Benhamou CL; Kaufman JM; Reginster JY
Bone; 2010 Apr; 46(4):1038-42. PubMed ID: 20026265
[TBL] [Abstract][Full Text] [Related]
24. Effectiveness of risedronate in osteoporotic postmenopausal women with inflammatory bowel disease: a prospective, parallel, open-label, two-year extension study.
Palomba S; Manguso F; Orio F; Russo T; Oppedisano R; Sacchinelli A; Falbo A; Tolino A; Zullo F; Mastrantonio P
Menopause; 2008; 15(4 Pt 1):730-6. PubMed ID: 18698280
[TBL] [Abstract][Full Text] [Related]
25. Two to three years of hormone replacement treatment in healthy women have long-term preventive effects on bone mass and osteoporotic fractures: the PERF study.
Bagger YZ; Tankó LB; Alexandersen P; Hansen HB; Møllgaard A; Ravn P; Qvist P; Kanis JA; Christiansen C
Bone; 2004 Apr; 34(4):728-35. PubMed ID: 15050905
[TBL] [Abstract][Full Text] [Related]
26. Strontium: new drug. Postmenopausal osteoporosis: too many unknowns.
Prescrire Int; 2005 Dec; 14(80):207-11. PubMed ID: 16397977
[TBL] [Abstract][Full Text] [Related]
27. Effect of teriparatide on bone mineral density and fracture in postmenopausal osteoporosis: meta-analysis of randomised controlled trials.
Han SL; Wan SL
Int J Clin Pract; 2012 Feb; 66(2):199-209. PubMed ID: 22257045
[TBL] [Abstract][Full Text] [Related]
28. Skeletal effects of raloxifene after 8 years: results from the continuing outcomes relevant to Evista (CORE) study.
Siris ES; Harris ST; Eastell R; Zanchetta JR; Goemaere S; Diez-Perez A; Stock JL; Song J; Qu Y; Kulkarni PM; Siddhanti SR; Wong M; Cummings SR;
J Bone Miner Res; 2005 Sep; 20(9):1514-24. PubMed ID: 16059623
[TBL] [Abstract][Full Text] [Related]
29. Calcium supplementation on bone loss in postmenopausal women.
Shea B; Wells G; Cranney A; Zytaruk N; Robinson V; Griffith L; Hamel C; Ortiz Z; Peterson J; Adachi J; Tugwell P; Guyatt G; ;
Cochrane Database Syst Rev; 2003; (4):CD004526. PubMed ID: 14584022
[TBL] [Abstract][Full Text] [Related]
30. [Postmenopausal hormonal treatment: conventional hormone replacement therapy or tibolone? Effects on bone].
Reginster JY
J Gynecol Obstet Biol Reprod (Paris); 2002 Oct; 31(6):541-9. PubMed ID: 12407324
[TBL] [Abstract][Full Text] [Related]
31. Avoidance of vertebral fractures in men with idiopathic osteoporosis by a three year therapy with calcium and low-dose intermittent monofluorophosphate.
Ringe JD; Dorst A; Kipshoven C; Rovati LC; Setnikar I
Osteoporos Int; 1998; 8(1):47-52. PubMed ID: 9692077
[TBL] [Abstract][Full Text] [Related]
32. Addition of monofluorophosphate to estrogen therapy in postmenopausal osteoporosis: a randomized controlled trial.
Reid IR; Cundy T; Grey AB; Horne A; Clearwater J; Ames R; Orr-Walker BJ; Wu F; Evans MC; Gamble GD; King A
J Clin Endocrinol Metab; 2007 Jul; 92(7):2446-52. PubMed ID: 17440020
[TBL] [Abstract][Full Text] [Related]
33. Interventions for preventing bone disease in kidney transplant recipients: a systematic review of randomized controlled trials.
Palmer SC; Strippoli GF; McGregor DO
Am J Kidney Dis; 2005 Apr; 45(4):638-49. PubMed ID: 15806466
[TBL] [Abstract][Full Text] [Related]
34. Meta-analyses of therapies for postmenopausal osteoporosis. IV. Meta-analysis of raloxifene for the prevention and treatment of postmenopausal osteoporosis.
Cranney A; Tugwell P; Zytaruk N; Robinson V; Weaver B; Adachi J; Wells G; Shea B; Guyatt G;
Endocr Rev; 2002 Aug; 23(4):524-8. PubMed ID: 12202467
[TBL] [Abstract][Full Text] [Related]
35. Meta-analyses of therapies for postmenopausal osteoporosis. V. Meta-analysis of the efficacy of hormone replacement therapy in treating and preventing osteoporosis in postmenopausal women.
Wells G; Tugwell P; Shea B; Guyatt G; Peterson J; Zytaruk N; Robinson V; Henry D; O'Connell D; Cranney A;
Endocr Rev; 2002 Aug; 23(4):529-39. PubMed ID: 12202468
[TBL] [Abstract][Full Text] [Related]
36. Slow-release sodium fluoride in the management of postmenopausal osteoporosis. A randomized controlled trial.
Pak CY; Sakhaee K; Piziak V; Peterson RD; Breslau NA; Boyd P; Poindexter JR; Herzog J; Heard-Sakhaee A; Haynes S; Adams-Huet B; Reisch JS
Ann Intern Med; 1994 Apr; 120(8):625-32. PubMed ID: 8135445
[TBL] [Abstract][Full Text] [Related]
37. Calcium supplementation on bone loss in postmenopausal women.
Shea B; Wells G; Cranney A; Zytaruk N; Robinson V; Griffith L; Hamel C; Ortiz Z; Peterson J; Adachi J; Tugwell P; Guyatt G; ;
Cochrane Database Syst Rev; 2004; (1):CD004526. PubMed ID: 14974070
[TBL] [Abstract][Full Text] [Related]
38. Effect of Growth Hormone Treatment on Fractures and Quality of Life in Postmenopausal Osteoporosis: A 10-Year Follow-Up Study.
Krantz E; Trimpou P; Landin-Wilhelmsen K
J Clin Endocrinol Metab; 2015 Sep; 100(9):3251-9. PubMed ID: 26312576
[TBL] [Abstract][Full Text] [Related]
39. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis.
Tang BM; Eslick GD; Nowson C; Smith C; Bensoussan A
Lancet; 2007 Aug; 370(9588):657-66. PubMed ID: 17720017
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of alphacalcidol and calcitriol in primary and corticosteroid-induced osteoporosis: a meta-analysis of their effects on bone mineral density and fracture rate.
Richy F; Ethgen O; Bruyere O; Reginster JY
Osteoporos Int; 2004 Apr; 15(4):301-10. PubMed ID: 14740153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
